Teachers are stressed. Students are struggling. Parents are shouldering more responsibilities than ever before. While the controversy surrounding when and how schools should reopen has led to policy debates and changes in family dynamics, UNC epidemiologists and education researchers find hope in the lessons from this year.
SARS-CoV-2 variants may seem like a scary new chapter in the pandemic, but coronavirus experts expected their arrival. Scientists in the UNC School of Medicine and Gillings School of Global Public Health are tracking the variants to learn how they differ and affect the world’s chance of ending this pandemic.
Millions of people are unemployed, many industries are struggling, and some businesses will never open again. Will we recover? UNC economists and financial analysts remain cautiously optimistic.
Graduate student Rachel Woodul spent two years researching what might happen to hospital capacity when the next pandemic strikes. When it arrived, she compared what her model — and others’ — got wrong to improve how we react to public health crises in the future.
For some COVID-19 patients, the initial infection is just the start of the battle. Post-COVID syndrome occurs when a person's symptoms continue long after their infection ends. A new clinic at UNC hopes to not only help these patients, but also provide researchers with valuable data about this strange syndrome.
Rachel Woodul is a PhD student in the Department of Geography within the UNC College of Arts & Sciences and a research assistant at the Carolina Population Center. She uses geographic information systems to model infectious disease spread, with a specific focus on epidemics and pandemics.
For decades, scientists warned of the potential for a global coronavirus outbreak. But when SARS-CoV-2 emerged, no therapeutics, drugs, or vaccines were readily available. The Rapidly Emerging Antiviral Drug Development Initiative (READDI) — founded by researchers at UNC and the Structural Genomics Consortium — is not only finding solutions to the COVID-19 pandemic, but also drugs and therapeutics for future viral outbreaks.
As one of the first research facilities in the U.S. to receive a COVID-19 sample and begin testing for potential therapies, UNC’s response to the threat of the coronavirus was immediate and remains unyielding. While some of our researchers have been studying coronaviruses for years, many others have pivoted the focus of their research, refitted their labs, and are working collaboratively to better execute a holistic response to the pandemic.
While the novel coronavirus has affected us all, it has drastically changed the lives of specific groups of people, from rural populations to long-term care residents to communities of color. Startling statistics among these groups have pushed UNC researchers from a variety of disciplines into action.
While COVID-19 has shaken the world, it has also pushed society to be more innovative and creative — two attributes that have been essential to the success of researchers at UNC. Carolina students, faculty, and staff are engaged in an abundance of projects, making UNC the most cited university in the nation for coronavirus research.